Showing results (41-50 of 82) with videos related to
Sort By:
Pageof 9
Molecular Systems Biology|March 20, 2019
Evidence that the human cell cycle is a series of uncoupled, memoryless phasesHui Xiao Chao, Randy I Fakhreddin, Hristo K Shimerov, et al.Practical Radiation Oncology|December 17, 2021
Dosimetric and Clinical Factors Associated With Breast Reconstruction Complications in Patients Receiving Postmastectomy RadiationJacob Hall, David Fried, Lawrence B Marks, et al.Proceedings of the National Academy of Sciences of the United States of America|April 11, 2007
Lung metastasis genes couple breast tumor size and metastatic spreadAndy J Minn, Gaorav P Gupta, David Padua, et al.Cancer|August 11, 2021
Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate-risk and high-risk head and neck squamous cell carcinomaBhishamjit S Chera, Siddharth H Sheth, Shetal A Patel, et al.Head & Neck|August 30, 2020
Decline in circulating viral and human tumor markers after resection of head and neck carcinomaErin M Lopez, April Michelle Tanner, Eugenie Du, et al.Nature Communications|September 21, 2019
Genetic determinants of cellular addiction to DNA polymerase thetaWanjuan Feng, Dennis A Simpson, Juan Carvajal-Garcia, et al.Breast Cancer Research and Treatment|February 21, 2026
Investigating initial patterns of progression on first-line treatment in patients with de novo metastatic breast cancerEmily Huber, Gaorav P Gupta, Ryan Morse, et al.Nature|November 15, 2023
Stepwise requirements for polymerases δ and θ in theta-mediated end joiningSusanna Stroik, Juan Carvajal-Garcia, Dipika Gupta, et al.Molecular Cell|May 4, 2020
BRCA1 Mutational Complementation Induces Synthetic ViabilityJoseph Nacson, Daniela Di Marcantonio, Yifan Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2024
PEARL: A Phase Ib/II Biomarker Study of Adding Radiation Therapy to Pembrolizumab Before Neoadjuvant Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative Breast CancerAlice Y Ho, Stephen Shiao, Samantha A Kobald, et al.Pageof 9